Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 493, P. 152736 - 152736
Published: June 1, 2024
Language: Английский
Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 493, P. 152736 - 152736
Published: June 1, 2024
Language: Английский
Small, Journal Year: 2025, Volume and Issue: unknown
Published: April 23, 2025
Abstract Type I hypersensitivity reactions are the most common type of and can cause various symptoms in different body systems. Currently, there is no standard treatment for manifestations at sites. To address this challenge, a nanocomposite named tFNAs‐siRNA‐siRNA (TSS) designed based on tetrahedral framework nucleic acids (tFNAs). It loaded with two siRNAs enter through multi‐route administration. In terms realization siRNAs’ functions, TSS successfully delivers them downregulates expression Gab2 Syk, thereby inhibiting migration release granules to extracellular space RBL‐2H3 cells. Interestingly, also exhibits effect hindering Ca 2+ efflux from mitochondria stabilize energy metabolism. passive cutaneous anaphylaxis allergic rhinitis model, shows excellent anti‐allergic ability, demonstrates an advantage intraperitoneal injection, transdermal, transnasal routes sum, offers new therapeutic strategy multiple symptoms, highlighting application potential acids‐based administration delivery system.
Language: Английский
Citations
0Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 495, P. 153335 - 153335
Published: June 20, 2024
Language: Английский
Citations
3Small, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 16, 2024
Abstract Infected wounds are a complex disease involving bacterial infections and dysregulated inflammation. However, current research has mostly focused on inhibition rather than Thus, combined therapeutic strategies with anti‐bacterial anti‐inflammation efficacies urgently needed. Antibiotics the main treatment strategy for infections. excessive use of antibiotics throughout body can cause serious side effects. In addition, miRNA‐based therapeutics superior wounds, but their rapid degradation poor cellular uptake limit clinical application. Tetrahedral framework DNA (tFNA) is an ideal drug delivery system owing to its excellent stability remarkable transport ability. Herein, novel multi‐functional miRNA antibiotic co‐delivery based tFNA presented first time, called B/L. B/L heightened resistance serum codelivery After transdermal administration, specifically target TNF receptor‐associated factor 6(TRAF6) IL‐1receptor‐associated kinase 1(IRAK1), thereby regulating nuclear kappa‐B (NF‐𝜿B) thus effectively reducing inflammation promoting healing infected wounds. This provides versatile, simple, biocompatible, powerful platform personalized multiple diseases.
Language: Английский
Citations
3International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: 672, P. 125329 - 125329
Published: Feb. 7, 2025
Language: Английский
Citations
0Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 493, P. 152736 - 152736
Published: June 1, 2024
Language: Английский
Citations
2